---
layout: post
title: "Draft Amended Environmental Assessment for Production of AquAdvantage Salmon at the Bay Fortune and Rollo Bay Facilities on Prince Edward Island, Canada; Public Meeting; Request for Comments"
date: 2026-02-05 19:01:34 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-25002
original_published: 2022-11-17 00:00:00 +0000
significance: 8.00
---

# Draft Amended Environmental Assessment for Production of AquAdvantage Salmon at the Bay Fortune and Rollo Bay Facilities on Prince Edward Island, Canada; Public Meeting; Request for Comments

**Published:** February 05, 2026 19:01 UTC
**Source:** Federal Register
**Original Published:** November 17, 2022 00:00 UTC
**Document Number:** 2022-25002

## Summary

The Food and Drug Administration (FDA, the Agency, or we) is hosting a virtual public meeting entitled "Draft Amended Environmental Assessment for Production of AquAdvantage Salmon at the Bay Fortune and Rollo Bay Facilities on Prince Edward Island, Canada." The purpose of the public meeting is to obtain public input on a draft amended environmental assessment (EA) prepared by FDA in support of an approved new animal drug application (NADA 141-454) concerning AquAdvantage Salmon (AAS), in response to an order by the U.S. District Court, Northern District of California.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/11/17/2022-25002/draft-amended-environmental-assessment-for-production-of-aquadvantage-salmon-at-the-bay-fortune-and)
- API: https://www.federalregister.gov/api/v1/documents/2022-25002

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
